Belatacept
Products Belatacept was approved in many countries in 2011 as a powder for the preparation of an infusion solution concentrate (Nulojix). Structure and properties Belatacept is a soluble fusion protein consisting of a modified extracellular domain of human cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and a fragment of the Fc domain of a human IgG1 antibody. … Belatacept
